sulfan blue has been researched along with Carcinoma, Ductal, Breast in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 8 (47.06) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Frountzas, M; Karathanasis, P; Michalopoulos, NV; Schizas, D; Theodoropoulos, C; Vrakopoulou, GZ; Zografos, CG; Zografos, GC | 1 |
Barneveld, PC; Bavelaar-Croon, CD; Bosscha, K; Contant, CM; de Roos, WK; van la Parra, RF | 1 |
Gao, W; Guo, W; Ji, J; Liu, J; Tong, M; Zhang, L | 1 |
Inaji, H; Inoue, T; Nakano, Y; Nishi, T; Nishimae, A; Sawai, Y; Yamasaki, M | 1 |
Elder, EE; French, J; Kilby, CJ; Ngui, NK; Pathmanathan, N | 1 |
Frangioni, JV; Hutteman, M; Liefers, GJ; Lowik, CW; Mieog, JS; Schaafsma, BE; Vahrmeijer, AL; van de Velde, CJ; van der Vorst, JR; Verbeek, FP | 1 |
Ahmed, F; Hart, M; Joshi, M; McPherson, S | 1 |
Chan, CM; Chong, SF; Hung, WK; Mak, KL; Ying, M; Yip, AW | 1 |
Chhabra, A; Goyal, A; Mansel, RE; Newcombe, RG | 1 |
Butarelli, M; Houvenaeghel, G; Marchal, F; Olivier, JB; Verhaeghe, JL | 1 |
Cox, CE; Dhakal, HP; Lamichhane, N; Neupane, PR; Pradhan, M; Shrestha, BM; Thakur, BK | 1 |
Al Mufti, R; Filippakis, G; Hadjiminas, DJ; Lanitis, S; Lee, TH; Sidhu, V | 1 |
Fried, D; Salmon, RJ | 1 |
Bourgeois, D; Clough, KB; Freneaux, P; Nos, C; Salmon, RJ; Zafrani, B | 1 |
Bando, E; Michigishi, T; Minato, H; Miwa, K; Nakajima, K; Noguchi, M; Nonomura, A; Tonami, N; Tsugawa, K; Yokoyama, K | 1 |
Clough, KB; Falcou, MC; Fréneaux, P; Guilbert, S; Nos, C; Salmon, RJ | 1 |
Botella-Estrada, R; Carbonell, M; Giménez, J; Guillén, C; Hernández, D; Martínez, MA; Vázquez, C | 1 |
4 trial(s) available for sulfan blue and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Prospective Studies; Rosaniline Dyes | 2016 |
Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Fluorescence; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Indocyanine Green; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Spectroscopy, Near-Infrared | 2012 |
Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Frozen Sections; Humans; Isotope Labeling; Middle Aged; Prospective Studies; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Treatment Outcome | 2005 |
Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; False Negative Reactions; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2006 |
13 other study(ies) available for sulfan blue and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Kounis syndrome after patent blue dye injection for sentinel lymph node biopsy.
Topics: Anaphylaxis; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Coronary Angiography; Dual Anti-Platelet Therapy; Electrocardiography; Female; Humans; Injections, Subcutaneous; Kounis Syndrome; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2020 |
A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; False Negative Reactions; Feasibility Studies; Female; Humans; Lymph Node Excision; Lymph Nodes; Mastectomy; Middle Aged; Neoplasms, Multiple Primary; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2014 |
Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Follow-Up Studies; Humans; Indocyanine Green; Lymph Nodes; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2014 |
Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Fluorescence; Follow-Up Studies; Humans; Image-Guided Biopsy; Immunoenzyme Techniques; Indocyanine Green; Lymph Nodes; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2016 |
Adverse reaction; patent blue turning patient blue.
Topics: Aged; Anaphylaxis; Breast Neoplasms; Carcinoma, Ductal, Breast; Color; Coloring Agents; Female; Humans; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin; Urticaria | 2012 |
[Functional anatomy of the lymphatic drainage of the breast: contribution of sentinel lymph node biopsy].
Topics: Axilla; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Lymph; Lymph Nodes; Lymphatic Vessels; Mastectomy, Radical; Nipples; Pectoralis Muscles; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2006 |
Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Cancer Care Facilities; Carcinoma, Ductal, Breast; Female; Humans; Middle Aged; Nepal; Palpation; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2007 |
Atypical anaphylactic reaction to Patent Blue during sentinel lymph node biopsy for breast cancer.
Topics: Adult; Anaphylaxis; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2008 |
[Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; False Negative Reactions; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Predictive Value of Tests; Rosaniline Dyes; Sensitivity and Specificity | 1998 |
[Identification of sentinel lymph node in breast cancer: experience from the Institut Curie].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Rosaniline Dyes | 1999 |
Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Female; Humans; Intraoperative Care; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Particle Size; Preoperative Care; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2000 |
Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Clinical Competence; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Quality Control; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2001 |
Anaphylaxis after peritumoral injection of sulphan blue 1% for identification of the sentinel node in lymphatic mapping of the breast.
Topics: Anaphylaxis; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Intradermal Tests; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2001 |